GSK announces appointment of Philippe Fauchet as President of GSK Japan
GSK announced the appointment of Philippe Fauchet as President of GSK Japan. Philippe will report to Marc Dunoyer, who takes the new role as Chairman of GSK Japan. Marc will continue to take overall leadership responsibility for GSK’s Pharmaceuticals business across the Asia Pacific/ Japan Region.
Philippe joins GSK from Sanofi Aventis where he was Senior Vice President, Business Development. He joined Sanofi in 1996, and headed up the Eastern Europe region from 1997, before becoming Vice President, Eastern Europe for Sanofi-Synthélabo in 1999. Philippe Fauchet took over as head of Sanofi-Synthélabo’s Japanese operations in June 2001 and was appointed as Senior Vice President Pharmaceuticals Operations, Japan in May 2005.
Philippe is a graduate of HEC (Ecole des Hautes Etudes Commerciales), and also holds a law degree. He joined Roussel Uclaf in 1984, and held a number of posts in France, Japan and Korea, before becoming Vice President of the Asia-Pacific region for Hoechst Marion Roussel in 1995.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
